Print ISSN:-2394-4781

Online ISSN:-2394-4994

CODEN : IJCACT


Article Metrics




Downlaod Files

   


Article Access statistics

Viewed: 1218

PDF Downloaded: 745


Attenuation of haemodynamic response to laryngoscopy and endotracheal intubation a comparative study between I.V. labetalol and I.V. lignocaine


Full Text PDF Share on Facebook Share on Twitter


Original Article

Author Details : S Kaladhar, Viditha Korukonda*

Volume : 7, Issue : 4, Year : 2020

Article Page : 676-680

https://doi.org/10.18231/j.ijca.2020.121



Suggest article by email

Get Permission

Abstract

Introduction: One of the most common procedures performed by the anaesthisiologists is the Endotracheal Intubation. During this procedure, hemodynamic changes, which may be rapid and dramatic and adverse to the patient may occur. Lignocaine is an excellent drug for the attenuation of pressor events and Labetalol is a potent antihypertensive drug.
Materials and Methods: 50 patients between the ages 18 to 60 years who were scheduled for various procedures under general anaesthesia with ASA Grade I status were included into the study and divided into 2 groups of 25 each. One group was given intravenous Labetalol 0.75mg/kg 10 minutes before intubation and the other group received intravenous injection of Lignocaine hydrochloride(without preservative) 2% in a dose of 1.5 mg/kg over a period of 10 seconds, before 90 seconds of laryngoscopy and intubation.
Results: The parameters were lower in Labetalol group (P<0> Conclusion: Labetalol given intravenous was more advantageous compared to other methods for attenution of hemodynamic changes after laryngoscopy and intubation as it has a good attenuation of pressor response and heart rate and provides a good intra operative profession against haemodynamics response to surgical stimuli.

Keywords: Labetalol, Lignocaine, Haemodynamic changes, Intravenous.



How to cite : Kaladhar S , Korukonda V, Attenuation of haemodynamic response to laryngoscopy and endotracheal intubation a comparative study between I.V. labetalol and I.V. lignocaine. Indian J Clin Anaesth 2020;7(4):676-680


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.